Inactive Instrument

PHARMAGEST INTER. Share Price Euronext Paris

Equities

FR0000077687

IT Services & Consulting

End-of-day quote Euronext Paris
- EUR - Intraday chart for PHARMAGEST INTER.

Financials

Sales 2023 220M 236M 18.86B Sales 2024 * 231M 249M 19.86B Capitalization 872M 938M 74.83B
Net income 2023 47M 50.58M 4.03B Net income 2024 * 49M 52.73M 4.21B EV / Sales 2023 4.18 x
Net cash position 2023 * 35.92M 38.66M 3.08B Net cash position 2024 * 64.17M 69.05M 5.51B EV / Sales 2024 * 3.49 x
P/E ratio 2023
19.5 x
P/E ratio 2024 *
17.4 x
Employees -
Yield 2023 *
2.09%
Yield 2024 *
2.3%
Free-Float 32.43%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 31/12/90
Founder 65 24/01/96
Director of Finance/CFO - 31/12/22
Members of the board TitleAgeSince
Founder 65 24/01/96
Director/Board Member 46 26/06/17
Director/Board Member 59 31/12/99
More insiders
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (74%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (14.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (89.7%), Italy (5.4%), Belgium (2.9%), Germany (1%), the United Kingdom (0.8%) and Ireland (0.2%).
More about the company